Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cecilia Y. S. Ho"'
Autor:
Ava Kwong, Vivian Yvonne Shin, Cecilia Y. S. Ho, Chun Hang Au, Thomas P. Slavin, Jeffrey N. Weitzel, Tsun-Leung Chan, Edmond S. K. Ma
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Germline TP53 mutations are associated with Li-Fraumeni syndrome, a severe and rare hereditary cancer syndrome. Despite the rarity of germline TP53 mutations, the clinical implication for mutation carriers and their families is si
Externí odkaz:
https://doaj.org/article/00741944e70547149fff3695430a3e4a
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2, p 889 (2021)
The germline carrier of the BRCA1 pathogenic mutation has been well proven to confer an increased risk of breast and ovarian cancer. Despite BRCA1 biallelic pathogenic mutations being extremely rare, they have been reported to be embryonically lethal
Externí odkaz:
https://doaj.org/article/737d79111c7245cbb72f3e37a2057b6a
Autor:
Elaine Y. L. Wong, Dona N. Ho, Edmond Sk Ma, Tsun Leung Chan, Chun Hang Au, Yvonne Chung, Ava Kwong, Vivian Y. Shin, Cecilia Y. S. Ho
Publikováno v:
JCO Precision Oncology. :1044-1047
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae71c08f1dc0c51039d52abcf6a62cd2
https://doi.org/10.1200/po.20.00454
https://doi.org/10.1200/po.20.00454
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2635
Background: The National Comprehensive Cancer Network (NCCN) testing criteria for the high-penetrance breast cancer susceptibility genes, specifically BRCA1, BRCA2, CDH1, PALB2, PTEN, and TP53, have been recently modified in 2023 to 2023 v.1. The fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a814ff42cdf04f4bed3b8f0f1851782
https://doi.org/10.3390/cancers15092635
https://doi.org/10.3390/cancers15092635
Autor:
Jeffrey N. Weitzel, Edmond S. K. Ma, Cecilia Y. S. Ho, Ava Kwong, Vivian Y. Shin, T. K. Chan, Thomas P. Slavin, Chun Hang Au
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background Germline TP53 mutations are associated with Li-Fraumeni syndrome, a severe and rare hereditary cancer syndrome. Despite the rarity of germline TP53 mutations, the clinical implication for mutation carriers and their families is significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::653095779e41b8ccbd9e34466dd65480
http://link.springer.com/article/10.1186/s12885-020-07476-y
http://link.springer.com/article/10.1186/s12885-020-07476-y
Autor:
Ava, Kwong, Chun Hang, Au, Vivian Y, Shin, Dona N, Ho, Elaine Y L, Wong, Cecilia Y S, Ho, Yvonne, Chung, Tsun Leung, Chan, Edmond S K, Ma
Publikováno v:
JCO precision oncology. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80bde767db4749cb185bec4ab767d9eb
https://pubmed.ncbi.nlm.nih.gov/34994627
https://pubmed.ncbi.nlm.nih.gov/34994627
Autor:
Chun Hang Au, Karen K. L. Chan, T. K. Chan, Hextan Y.S. Ngan, Aleena Khalid, Vivian Y. Shin, Ava Kwong, Edmond S. K. Ma, Cecilia Y. S. Ho
Publikováno v:
Cancers, Vol 13, Iss 4195, p 4195 (2021)
Cancers
Volume 13
Issue 16
Cancers
Volume 13
Issue 16
The prevalence of the PALB2 mutation in breast cancer varies across different ethnic groups
hence, it is of intense interest to evaluate the cancer risk and clinical association of the PALB2 mutation in Chinese breast and/or ovarian cancer patie
hence, it is of intense interest to evaluate the cancer risk and clinical association of the PALB2 mutation in Chinese breast and/or ovarian cancer patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a2759c8c1e241a40d12afe11f37191
https://www.mdpi.com/2072-6694/13/16/4195
https://www.mdpi.com/2072-6694/13/16/4195
Autor:
Ava, Kwong, Vivian Y, Shin, Jiawei, Chen, Isabella W Y, Cheuk, Cecilia Y S, Ho, Chun H, Au, Karen K L, Chan, Hextan Y S, Ngan, Tsun L, Chan, James M, Ford, Edmond S K, Ma
Publikováno v:
The Journal of molecular diagnostics : JMD. 22(4)
Differences in the mutation spectrum across ethnicities suggest the importance of identifying genes in addition to common high penetrant genes to estimate the associated breast cancer risk in China. A total of 1338 high-risk breast cancer patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::65c2d1a7568895caf7c3a3d62bb8538c
https://pubmed.ncbi.nlm.nih.gov/32068069
https://pubmed.ncbi.nlm.nih.gov/32068069
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 889, p 889 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
The germline carrier of the BRCA1 pathogenic mutation has been well proven to confer an increased risk of breast and ovarian cancer. Despite BRCA1 biallelic pathogenic mutations being extremely rare, they have been reported to be embryonically lethal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9b2e8abda156b668f37b893fd32049
https://doi.org/10.3390/ijms22020889
https://doi.org/10.3390/ijms22020889
Autor:
Ka Fai To, Ailong Huang, Ben C.B. Ko, Margaret H.L. Ng, Paul B.S. Lai, Ming-Tat Ling, Anthony W.H. Chan, Jun Yu, Xue Fei Cai, Suk Hang Cheng, Bin Zhang, Anthony W.I. Lo, Juan Chen, Ho Keung Ng, Cecilia Y. S. Ho, Nathalie Wong
Publikováno v:
Cancer Research. 71:4138-4149
Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis. Treatment of HCC is complicated by the fact that the disease is often diagnosed at an advanced stage when it is no longer amenable to curative surgery, and current syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d74d4ba988934ee2b85fe17a4ac7986
https://doi.org/10.1158/0008-5472.can-10-4274
https://doi.org/10.1158/0008-5472.can-10-4274